EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $217,654 | -5.0% | 7,672 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $229,134 | -99.9% | 7,839 | -49.4% | 0.00% | 0.0% |
| Q3 2022 | $205,205,000 | +59552.6% | 15,502 | +100.2% | 0.00% | -50.0% |
| Q2 2022 | $344,000 | -9.5% | 7,743 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $380,000 | -4.3% | 7,677 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | -8.7% | 7,796 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | +30.6% | 7,794 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $333,000 | +1.5% | 7,791 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $328,000 | -6.0% | 7,867 | +4.8% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | -99.9% | 7,505 | +7047.6% | 0.00% | -33.3% |
| Q3 2020 | $310,000,000 | – | 105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |